Gene · 8321
NIH grants1,683
NIH grants whose papers are about the gene, through NIH's grant-paper links.
941 to 960 of 1,683
Download this page as JSON| Grant | Title | FZD1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA118384 | LRIG Proteins in mammary gland development and carcinogenesis | 1 | 2016 |
| R01CA149646 | Glucose metabolism and ErbB2-mediated cancer progression | 1 | 2016 |
| R01CA154980 | Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression | 1 | 2016 |
| R01CA159467 | Cdk4/6 Inhibitor Therapy for Glioblastoma Multiforme | 1 | 2016 |
| R01CA159811 | Modulation of Oncogenic Signaling in Glioblastomas | 1 | 2016 |
| R01CA160821 | Cytochrome C Oxidase in Malignant Gliomas | 1 | 2016 |
| R01CA161294 | Erythropoietin and Breast Cancer Stem Cells | 1 | 2016 |
| R01CA163541 | Exploiting tumor stroma interactions for cancer therapy | 1 | 2016 |
| R01CA164331 | Identification of Inhibitors of the N-Terminal Region of the Androgen Receptor | 1 | 2016 |
| R01CA166197 | HDAC2 in HDAC inhibitor-based therapy for CRC | 1 | 2016 |
| R01DA033660 | Multigenerational Epigenetic Effects of Cannabis Exposure | 1 | 2016 |
| R01DK064678 | MLL3/4-complexes in nuclear receptor-mediated metabolism | 1 | 2016 |
| R01DK097084 | Ectopic adiposity in black men with high type 2 diabetes risk | 1 | 2016 |
| R01DK099226 | G Protein pathways as Novel Therapeutic and Diagnostic Targets in Liver Fibrosis | 1 | 2016 |
| R01GM042341 | Gene Expression in Amphibian Development | 1 | 2016 |
| R01GM047857 | Cell adhesion, signal transduction and cytoskeletal regulation in Drosophila | 1 | 2016 |
| R01GM081635 | Regulation of beta-catenin degradation during Wnt signal transduction | 1 | 2016 |
| R01GM083064 | Dissecting Mechanisms of Ubiquitination and Deubiquitination in Cell Cycle Contro | 1 | 2016 |
| R01GM103926 | Role of ubiquitination in the Wnt pathway | 1 | 2016 |
| R01GM106024 | Using ChAP-MS to Study Macromolecular Chromatin Composition during Transcription | 1 | 2016 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/grants?page=48